Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report ‘Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality’. The research focused on two technology enablers that have the potential to advance integration, and enable data to be used more effectively. Digital identity tools, such as Electronic Health Records (EHRs), based on standardized data and protocols that can be accessed, used and updated by care providers across the health continuum – can make the collection and exchange of healthcare data much easier. Data analytics and AI can mine that data for connections and insights that will benefit both healthcare professionals and patients. This ranges from the identification of health trends at the level of an entire population, to more precise diagnosis, treatment and after care for individual patients.
The latest FHI report identifies the following key recommendations for the way in which health data is collected, shared and used, in order for countries to meet their goals of driving better value in healthcare:
•Strike the right balance in data protection and (de)regulation
•Foster adoption through education – only 47% of healthcare professionals surveyed and 24% of the general population felt knowledgeable about connected care technologies
•Secure buy-in through co-creation of solutions together with healthcare professionals and the general population
•Harmonize of data collection and use practices – countries with universal EHRs have a higher Value Measure than countries without universal EHRs (47.29 on average vs 39.67), as well as higher average levels of trust (67.79 vs. 62.99)
“The Future Health Index’s latest report shows that the smooth exchange of health information is central to delivering better value in healthcare,” said Jan Kimpen, Chief Medical Officer for Philips. “By connecting people, data and systems we can create a network that allows information to flow seamlessly across care providers, locations and systems. It is through data that the outcomes that define value are tracked, measured and improved. Yet, health systems around the world are still struggling to collect, organize, analyze and use health data in a meaningful way. The recommendations made in the FHI are designed to address these very challenges and provide actionable next steps that healthcare leaders can take to optimize the value provided by the digital tools they are investing in.”
FHI is a research-based platform designed to help determine the readiness of countries to address global health challenges and build sustainable, fit-for-purpose national health systems. Using the real-life learning of experts in the field, and insights uncovered in research, the FHI provides actionable recommendations for the healthcare industry; particularly around the adoption and implementation of crucial digital tools that can deliver more affordable, integrated and sustainable care. A key finding of the FHI is that integrating connected care technology into health systems can accelerate countries along the path to value-based healthcare.
To download the Future Health Index 2018 report in its entirety, please visit this webpage. For additional Future Health Index related content, please visit https://www.futurehealthindex.com/
Philips showcases integrated solutions for cardiovascular care at TCT 2018
Innovations in image-guided therapy designed to enhance clinician confidence and improve patient care
Amsterdam, the Netherlands and San Diego, California – At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (September 21 – 25, San Diego, California), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest solutions in interventional cardiology. These solutions combine imaging systems, planning and navigation software, and specialized diagnostic and therapeutic devices, helping clinicians conduct procedures that are fast, efficient and personalized.
Philips will showcase its latest innovations in image-guided therapy, addressing key concerns of cardiologists such as complex percutaneous coronary interventions (complex PCI), which account for a significant proportion of PCI procedures that treat the narrowing of coronary arteries. Azurion, Philips’ next generation image-guided therapy platform, provides clinicians with the control needed to perform efficient procedures. CoreVision, which can be seamlessly combined with Azurion, is the only system that intelligently integrates X-ray angiography imaging, IVUS, and iFR in a single view for the high level of diagnostic precision needed for today’s increasingly complex procedures. Combining Philips’ imaging systems, planning and navigation, and smart devices, physicians can take advantage of an integrated solution that supports improved care for complex PCI patients.
“Philips offers a unique portfolio of interventional cardiac technologies that cater to the complex needs of interventional cardiologists, enabling them to provide excellent treatment and care for their patients,” said Christopher Barys, Business Leader Image Guided Therapy Devices, Philips. “Using our integrated high-precision solutions, comprising Azurion augmented with CoreVision and combined with our IVUS and iFR technologies, we’re able to provide clinicians with the right tools to make confident diagnosis and treatment decisions for each patient.”
Latest advances in cardiac ultrasound for interventional procedures
This year at TCT, Philips will also showcase the recently-introduced EPIQ CVxi interventional cardiovascular ultrasound system. Specifically designed for use in the cath lab, the EPIQ CVxi with EchoNavigator streamlines communication between the interventional cardiologist and the echocardiographer during complex interventional exams, improving patient care and enhancing workflow. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigator helps interventional cardiologists oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3D during diagnostic or interventional procedures as the clinician can see multiple views at once.
Also on show will be the compact and portable Philips CX50 ultrasound system, which has been upgraded with new software features and compatibility with additional transducers, including the latest X8-2t TEE transducer for transesophageal echocardiography. Philips has pioneered transesophageal echocardiography, which places the ultrasound transducer close to the heart to enable confident diagnosis and treatment of structural heart diseases. Now, customers will be able to use a wider range of transducers, including the X8-2t TEE, across both their mobile and cart-based ultrasound systems.
For the full calendar of events, as well as general information about Philips’ presence at the show, visit www.philips.com/tct. Visit Philips at booth #1728 to experience innovative cardiac solutions and follow the #TCT2018 conversation on @PhilipsLiveFrom throughout the event.